Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
INSM Transcript
Insmed Incorporated (INSM) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Neutral3-2
Insmed Incorporated (INSM) Q4 2025 Earnings Call Transcript
Positive2-19
The earnings call summary and Q&A section indicate positive sentiment overall. Strong financial metrics and optimistic guidance, especially regarding BRINSUPRI and ARIKAYCE, suggest potential stock price growth. The strategic plan highlights multiple upcoming catalysts, including new drug launches and trials. Management's confidence in market access and revenue opportunities further supports a positive outlook. However, some concerns remain about physician prescribing depth and market access clarity. Despite these, the overall tone is optimistic, warranting a positive sentiment rating.
Insmed Incorporated (INSM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-12
Insmed Incorporated (INSM) Presents at Evercore 8th Annual Healthcare Conference Transcript
Neutral12-2
INSM Slides
Insmed Q4 2025 slides reveal strong BRINSUPRI launch, projects 139% revenue growth for 20262026-02-19
Insmed Q3 2025 slides reveal strong BRINSUPRI debut, ARIKAYCE growth accelerates2025-10-30
Insmed Q2 2025 slides reveal 19% revenue growth amid clinical pipeline advances2025-08-07
Insmed Q1 2025 slides: ARIKAYCE sales surge 23% as brensocatib launch approaches2025-05-08
INSM Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
